Xiaojing Du

4.9k total citations · 2 hit papers
93 papers, 2.2k citations indexed

About

Xiaojing Du is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaojing Du has authored 93 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 20 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Xiaojing Du's work include Head and Neck Cancer Studies (11 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (8 papers). Xiaojing Du is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (8 papers). Xiaojing Du collaborates with scholars based in China, United States and Australia. Xiaojing Du's co-authors include Hongxin Wang, Huijuan Jing, Xin Huang, Ling Mo, Xin Cao, Jun Ma, Ying Sun, Quanlin An, Chaoyang Ma and Li Wang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaojing Du

91 papers receiving 2.2k citations

Hit Papers

Facile synthesis of pH-re... 2021 2026 2022 2024 2021 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Facile synthesis of pH-responsive sodium alginate/carboxymethyl chitosan hydrogel beads promoted by hydrogen bond
    2021 221 citations Huijuan Jing, Xiaojing Du et al. profile →
  2. Carbohydrate-based drugs launched during 2000−2021
    2022 171 citations Xin Cao, Xiaojing Du et al. Acta Pharmaceutica Sinica B profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaojing Du 687 483 272 254 250 93 2.2k
Raimundo Fernandes de Araújo Júnior 651 0.9× 246 0.5× 201 0.7× 198 0.8× 161 0.6× 99 2.5k
Chia-Lang Fang 688 1.0× 185 0.4× 174 0.6× 245 1.0× 111 0.4× 56 2.5k
Aurigena Antunes de Araújo 583 0.8× 181 0.4× 215 0.8× 181 0.7× 111 0.4× 119 2.4k
Carolina Constantin 979 1.4× 750 1.6× 363 1.3× 207 0.8× 447 1.8× 136 3.5k
Xin Shen 1.5k 2.2× 272 0.6× 161 0.6× 179 0.7× 379 1.5× 94 3.1k
Aseem Bhatnagar 608 0.9× 162 0.3× 345 1.3× 217 0.9× 58 0.2× 157 3.0k
Rituraj Konwar 1.2k 1.7× 462 1.0× 142 0.5× 92 0.4× 199 0.8× 102 3.1k
Gurjeet Kaur 696 1.0× 185 0.4× 103 0.4× 140 0.6× 193 0.8× 135 1.8k
Jiaqi Huang 1.0k 1.5× 500 1.0× 239 0.9× 172 0.7× 371 1.5× 157 3.0k
Mohammed Al‐Qahtani 1.3k 1.9× 522 1.1× 248 0.9× 238 0.9× 551 2.2× 150 3.2k

Countries citing papers authored by Xiaojing Du

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Du more than expected).

Fields of papers citing papers by Xiaojing Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Du. The network helps show where Xiaojing Du may publish in the future.

Co-authorship network of co-authors of Xiaojing Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Du. A scholar is included among the top collaborators of Xiaojing Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Du. Xiaojing Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lingxiao, Shiguang Yang, Jie Li, et al.. (2025). YAP-activated NAT10 promotes hepatoblastoma progression by activating the pentose phosphate pathway. International Journal of Biological Sciences. 21(6). 2864–2879. 1 indexed citations
2.
Liu, Wenfeng, Ye Xu, Yifan Ma, et al.. (2025). Alisertib impairs the stemness of hepatocellular carcinoma by inhibiting purine synthesis. Journal of Biological Chemistry. 301(6). 108558–108558. 1 indexed citations
3.
Yan, Xiaohan, Le Kang, Yingjie Ji, et al.. (2024). TRPM8 inhibits substance P release from primary sensory neurons via PKA/GSK-3beta to protect colonic epithelium in colitis. Cell Death and Disease. 15(1). 91–91. 7 indexed citations
4.
5.
Mo, Ling, et al.. (2024). Goat casein hydrolysates alleviated insomnia in mice via modulating the level of neurotransmitters and the composition of gut microbiota. Food Science and Human Wellness. 14(1). 9250015–9250015. 3 indexed citations
6.
7.
Du, Xiaojing, Shan Wang, Zaixiang Lou, Chengyu Jiang, & Hongxin Wang. (2023). Preparation, characterization and functional properties of ternary composite nanoparticles for enhanced water solubility and bioaccessibility of lutein. Food Hydrocolloids. 144. 109039–109039. 23 indexed citations
8.
9.
Du, Xiaojing, et al.. (2023). HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype. Computational and Structural Biotechnology Journal. 21. 5174–5185. 5 indexed citations
10.
11.
Du, Xiaojing, Xiaoling Lü, & Xin Cao. (2023). Gantt chart for updated OS and PFS after cancer targeted therapy. 1(1). 100008–100008. 5 indexed citations
12.
Shi, Qisong, et al.. (2022). Social Support and Self-Efficacy as Mediating Factors Affecting the Association Between Depression and Medication Adherence in Older Patients with Coronary Heart Disease: A Multiple Mediator Model with a Cross-Sectional Study. SHILAP Revista de lepidopterología. 34 indexed citations
13.
Cao, Xin, Xiaojing Du, Quanlin An, et al.. (2022). Carbohydrate-based drugs launched during 2000−2021. Acta Pharmaceutica Sinica B. 12(10). 3783–3821. 171 indexed citations breakdown →
14.
Du, Xiaojing, et al.. (2022). Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma. Journal of Immunology Research. 2022. 1–12. 1 indexed citations
15.
Chen, Qiuxiang, et al.. (2022). Bioinformatics Analysis Revealing the Correlation between NF-κB Signaling Pathway and Immune Infiltration in Gastric Cancer. Computational and Mathematical Methods in Medicine. 2022. 1–27. 2 indexed citations
16.
Du, Xiaojing, et al.. (2022). Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma. Molecular Oncology. 16(20). 3703–3719. 22 indexed citations
17.
Du, Xiaojing, et al.. (2022). A Novel Hypoxia Related Marker in Blood Link to Aid Diagnosis and Therapy in Osteoarthritis. Genes. 13(9). 1501–1501. 11 indexed citations
18.
Du, Xiaojing, et al.. (2022). Prevalence of Disability among the Chinese Older Population: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 19(3). 1656–1656. 33 indexed citations
19.
Du, Xiaojing, Biwei Yang, Quanlin An, et al.. (2021). Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. The Innovation. 2(2). 100103–100103. 101 indexed citations
20.
Li, Ying-Qin, Xiao-Jing Yang, Xiaojing Du, et al.. (2018). RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma. Clinical Cancer Research. 24(24). 6495–6508. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raimundo Fernandes de Araújo Júnior Breakdown of academic impact, for papers by Chia-Lang Fang Breakdown of academic impact, for papers by Aurigena Antunes de Araújo Breakdown of academic impact, for papers by Carolina Constantin Breakdown of academic impact, for papers by Xin Shen Breakdown of academic impact, for papers by Aseem Bhatnagar Breakdown of academic impact, for papers by Rituraj Konwar Breakdown of academic impact, for papers by Gurjeet Kaur Breakdown of academic impact, for papers by Jiaqi Huang Breakdown of academic impact, for papers by Mohammed Al‐Qahtani
Rankless by CCL
2026